Zoekresultaten - 6 results
Molecular test algorithms for breast tumours
Commission of Personalized Medicine (ComPerMed) has applied, for the breast tumours, the same methodology as previously applied for the digestive tumours. Meaning, the different molecular tests, represented in ...
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.
knowledge, and screening compliance were obtained via self-administered questionnaire. RESULTS: Few respondents had low socioeconomic status. Mean total time and travel costs and direct non-medical cost per ...
CanCon European Guide on Quality Improvement in Comprehensive Cancer Control- Chapter 4: Screening
decisionmaking, informed political commitment and broad stakeholder involvement in order to build strong professional support for the aims and means of the screening programme. Governance structures recommended ...
Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening.
of CIN3 + or invasive cervical cancer after a negative hrHPV DNA test is significantly lower than after a negative Pap smear. This means that screening intervals can be extended safely up to five ...
IPAAC Rapport WP4: Cancer control policy interview survey
programme. Some groups have been found to have systematically lower compliance to organized screening programs. Special attention should be given to the means of reaching, informing and inviting these specific ...
Thematic Working Group 5: Personalized Medicine
of what ‘personalized medicine’ means and came to a working definition for this group. A litterature study was performed and relevant information was compiled into a review paper. Health Topics: ...